Baltimore, Maryland Clinical Trials

A listing of Baltimore, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1664 clinical trials
Featured trial
An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
 (1.7 away) Contact site
  • 786 views
  • 25 Mar, 2021
  • +29 other locations
Featured trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Research Center (DNU)
 (0.8 away) Contact site
  • 2110 views
  • 25 Mar, 2021
  • +106 other locations
Featured trial
Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-7)

This Phase 2 study evaluates the clinical activity and safety of MRTX849 in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS.

KRAS
pembrolizumab
The Sidney Kimmel Comprehensive Cancer Center
 (1.7 away) Contact site
  • 17 views
  • 04 Jan, 2022
  • +55 other locations
Featured trial
ATR Inhibitor BAY 1895344 plus pembrolizumab in advanced solid tumors (GI, Pancreatic, mCRPC, NSCLC)

This clinical study aims to investigate if impairment of the deoxyribonucleic acid damage repair (DDR) pathway by the Elimusertib in combination with blockade of the PD-1/PD-L1 pathway by pembrolizumab, may improve antitumor responses in advanced cancer patients with DDR aberrations, at an acceptable safety profile and an expected positive benefit/risk …

pembrolizumab
measurable disease
EGFR
Johns Hopkins Hospital/Health System
 (1.7 away) Contact site
  • 12 views
  • 13 Oct, 2021
  • +10 other locations
Featured trial
[Remote] Genomic Discoveries in African-Americans.

This study is looking for African-American families that have been affected by Alzheimer’s. The study wants to learn about the genetic causes of Alzheimer’s.

dementia
[Remote] Genomic Discoveries in African-Americans.
 (1.2 away) Contact site
  • 66 views
  • 26 May, 2021
  • +243 other locations
Featured trial
A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients With gBRCA Mutated Metastatic Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy

A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients With gBRCA Mutated Metastatic Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy

Johns Hopkins-The Sidney Kimmel Comprehensive Cancer Center
 (1.9 away) Contact site
  • 333 views
  • 08 Nov, 2020
  • +26 other locations
Featured trial
Neural Network Connectivity of Financial Capacity in Mild Cognitive Impairment

This study is looking for people over the age of 60 who have 1) normal cognition OR 2) mild cognitive impairment. This research is being done to understand the brain’s structure and function in relation to our ability to perform daily financial skills. Understanding this will help to better identify …

Johns Hopkins Bayview Medical Center
 (3.8 away) Contact site
  • 0 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Actigraphy in Agitation

This study is looking for people over the age of 55 who have 1) normal cognition OR 2) Alzheimer’s disease. The study is interested in the relationship between cognition, agitation, and patterns of sleep and activity (circadian rhythms).

agitation
Johns Hopkins Bayview Medical Center
 (3.8 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • 1 location
Featured trial
BIOCARD Study

To identify measures in cognitively normal individuals that predict progression to mild cognitive impairment and/or dementia. The overall goal is improve our understanding of the earliest phases of Alzheimer's disease.

Johns Hopkins University
 (1.7 away) Contact site
  • 0 views
  • 05 Feb, 2021
  • 1 location
Featured trial
[Online] Conversations with Alzheimer's Patients

The purpose of this study is to collect audio recordings between Alzheimer's patients and their caregivers in order to analyze the conversations for patterns of language use. Caregivers will fill out a questionnaire that asks about the caregiver, the Alzheimer’s patient they care for, and their daily routines with the …

[Online] Conversations with Alzheimer's Patients
 (1.2 away) Contact site
  • 10 views
  • 16 Apr, 2021
  • +241 other locations